Major deals involving U.S. drugmakers and biotechs over the past decade

• click to rate

  Posted by Two Blokes Jul 9 - Filed in Stock - 4 views
  
  Merck is acquiring UK-based Verona Pharma for about $10 billion, as part of the U.S. drugmaker's strategy to diversify beyond its blockbuster cancer treatment Keytruda.